What does PHARMAVRAI do?

PHARMAVRAI is a pharmacy in Huy. Private Limited, started on 8 May 2014, 1 establishment.

What is the address of PHARMAVRAI?

The registered office of PHARMAVRAI is located at Rue Delloye-Matthieu 11, 4500 Huy.

Is PHARMAVRAI still active?

Yes. According to the CBE (29 September 2026) PHARMAVRAI is active, legal situation “Normale toestand”, started on 8 May 2014.

Is PHARMAVRAI registered on Peppol?

Yes, PHARMAVRAI is registered on the Peppol network with ID 0208:0552535853.

What is the enterprise number of PHARMAVRAI?

The enterprise number of PHARMAVRAI is BE0552535853.

When was PHARMAVRAI founded?

PHARMAVRAI was founded on 8 May 2014.

Who are the directors of PHARMAVRAI?

According to the 2025 annual accounts, the directors of PHARMAVRAI are: MARIE VANVOLSEM ANNABELLE, MARIE VANVOLSEM CLARISSE.

Is PHARMAVRAI a reliable company?

Databakkes does not pass judgement; this is what the sources say: Active according to the CBE since 8 May 2014; 5 annual accounts filed, latest fiscal year 2025; 2 directors known from the annual account.

How much profit did PHARMAVRAI make in 2025?

PHARMAVRAI posted a profit after taxes of € 85,639 in financial year 2025.

What is the revenue of PHARMAVRAI?

As a small company, PHARMAVRAI is not required to publish revenue in its annual accounts. In financial year 2025, its added value was € 217,329.

How many employees does PHARMAVRAI have?

According to the 2025 annual accounts, PHARMAVRAI has 0 full-time equivalents (FTE).

Does PHARMAVRAI have a website?

Yes, PHARMAVRAI has a website at pharmavrai.com.

PHARMAVRAI (Private Limited) - Huy - BE0552535853

Dossier PHARMAVRAI, printed on 29 September 2026 from databakkes.be/en/0552535853/pharmavrai. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Financials

Financial year 2025

PHARMAVRAI from Huy, company number BE0552535853, closed financial year 2025 with a result of € 85,639 after tax. For that financial year PHARMAVRAI recorded a gross margin of € 217,329 and equity of € 306,070. Compared with financial year 2024, the result moved from € 54,165 to € 85,639. Profitable, and profit is growing. The company holds a healthy buffer. Debts are under control. The most recent annual accounts were filed with the National Bank of Belgium on July 22, 2026.

What it is worth Healthy

€ 306,070

▼ 7% vs 2024

Assets minus debts, by the books. What is left if everything were sold and paid today.

Profit Growing

€ 85,639

▲ 58% vs 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 169,817

▼ 1% vs 2024

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Pays out

€ 107,846 paid out

More than the year’s profit went to the shareholders; reserves fell.

People and assets in 2025

Full-time equivalents

Average over the fiscal year, from the social balance sheet.

Vehicles and equipment

€ 6,812

▲ 12% vs 2024

Book value of vehicles, furniture and equipment.

Debts at end 2025

Bank debt ≈ 7 years to go The accounts give the long-term loan and the part due within the year. The remainder divided by that part is the number of years at an equal pace; a new loan or early repayment changes it.

€ 407,022

▼ 13% vs 2024

€ 62,362 is repaid this year. At this pace the long-term loan is gone in ≈ 7 years.

Owed to suppliers

€ 40,253

▼ 37% vs 2024

Supplier invoices still open on the last day of the fiscal year.

Taxes and wages

€ 17,459

▲ 102% vs 2024

Taxes, VAT and social contributions still to pay.

Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Gross margin	€ 34,045 Gross margin 2022: € 34,045 First fiscal year in the series	€ 128,784 Gross margin 2023: € 128,784 ▲ 278% vs 2022 (€ 34,045) Favourable step	€ 168,805 Gross margin 2024: € 168,805 ▲ 31% vs 2023 (€ 128,784) Favourable step	€ 217,329 Gross margin 2025: € 217,329 ▲ 29% vs 2024 (€ 168,805) Favourable step	▲ 29%
Profit after taxes	€ 99,057 Profit after taxes 2022: € 99,057 First fiscal year in the series	€ 20,602 Profit after taxes 2023: € 20,602 ▼ 79% vs 2022 (€ 99,057) Unfavourable step	€ 54,165 Profit after taxes 2024: € 54,165 ▲ 163% vs 2023 (€ 20,602) Favourable step	€ 85,639 Profit after taxes 2025: € 85,639 ▲ 58% vs 2024 (€ 54,165) Favourable step	▲ 58%
Equity	€ 253,510 Equity 2022: € 253,510 First fiscal year in the series	€ 274,112 Equity 2023: € 274,112 ▲ 8% vs 2022 (€ 253,510) Favourable step	€ 328,276 Equity 2024: € 328,276 ▲ 20% vs 2023 (€ 274,112) Favourable step	€ 306,070 Equity 2025: € 306,070 ▼ 7% vs 2024 (€ 328,276) Unfavourable step	▼ 7%
Total debts	€ 523,920 Total debts 2022: € 523,920 First fiscal year in the series	€ 639,762 Total debts 2023: € 639,762 ▲ 22% vs 2022 (€ 523,920) Unfavourable step	€ 556,939 Total debts 2024: € 556,939 ▼ 13% vs 2023 (€ 639,762) Favourable step	€ 574,199 Total debts 2025: € 574,199 ▲ 3% vs 2024 (€ 556,939) Unfavourable step	▲ 3%
Cash	€ 9,205 Cash 2022: € 9,205 First fiscal year in the series	€ 140,217 Cash 2023: € 140,217 ▲ € 131,012 vs 2022 (€ 9,205) Favourable step	€ 171,367 Cash 2024: € 171,367 ▲ 22% vs 2023 (€ 140,217) Favourable step	€ 169,817 Cash 2025: € 169,817 ▼ 1% vs 2024 (€ 171,367) Unfavourable step	▼ 1%
Land & buildings	€ 150,939 Land & buildings 2022: € 150,939 First fiscal year in the series	€ 145,527 Land & buildings 2023: € 145,527 ▼ 4% vs 2022 (€ 150,939) Unchanged	€ 140,114 Land & buildings 2024: € 140,114 ▼ 4% vs 2023 (€ 145,527) Unchanged	€ 134,702 Land & buildings 2025: € 134,702 ▼ 4% vs 2024 (€ 140,114) Unchanged	▼ 4%
Retained profit	€ 203,510 Retained profit 2022: € 203,510 First fiscal year in the series	€ 224,112 Retained profit 2023: € 224,112 ▲ 10% vs 2022 (€ 203,510) Favourable step	€ 278,276 Retained profit 2024: € 278,276 ▲ 24% vs 2023 (€ 224,112) Favourable step	€ 256,070 Retained profit 2025: € 256,070 ▼ 8% vs 2024 (€ 278,276) Unfavourable step	▼ 8%
Dividend	€ 30,117 Dividend 2022: € 30,117 First fiscal year in the series	€ 0 Dividend 2023: € 0 ▼ 100% vs 2022 (€ 30,117) Unchanged	€ 0 Dividend 2024: € 0 Unchanged (€ 0) Unchanged	€ 107,846 Dividend 2025: € 107,846 Unchanged (€ 0) Unchanged
Bank debt	€ 442,464 Bank debt 2022: € 442,464 First fiscal year in the series	€ 535,361 Bank debt 2023: € 535,361 ▲ 21% vs 2022 (€ 442,464) Unfavourable step	€ 468,321 Bank debt 2024: € 468,321 ▼ 13% vs 2023 (€ 535,361) Favourable step	€ 407,022 Bank debt 2025: € 407,022 ▼ 13% vs 2024 (€ 468,321) Favourable step	▼ 13%
Balance sheet total	€ 777,430 Balance sheet total 2022: € 777,430 First fiscal year in the series	€ 913,873 Balance sheet total 2023: € 913,873 ▲ 18% vs 2022 (€ 777,430) Unchanged	€ 885,216 Balance sheet total 2024: € 885,216 ▼ 3% vs 2023 (€ 913,873) Unchanged	€ 880,268 Balance sheet total 2025: € 880,268 ▼ 1% vs 2024 (€ 885,216) Unchanged	▼ 1%
Employees (FTE)	-	0.2 Employees (FTE) 2023: 0.2 First fiscal year in the series	0 Employees (FTE) 2024: 0 ▼ 0.2 vs 2023 (0.2) Unchanged	0 Employees (FTE) 2025: 0 Unchanged (0) Unchanged

Key figures of PHARMAVRAI, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.

What happened to PHARMAVRAI?

What happened at PHARMAVRAI in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

Jul 22, 2026 New annual accounts for financial year 2025: profit of € 85,639 (▲ 58% vs 2024). Source: NBB ↗
May 8, 2014 New establishment in Huy. KBO
May 8, 2014 Start of the company according to the CBE. KBO

In short

From € 99,057 profit in 2022 to € 85,639 profit in 2025.

Paid € 103,654 in corporate taxes since 2022.

Best year ever: 2022, with € 99,057 profit.

Paid out € 137,963 in dividends to the owners in total.

Original PDFs at the National Bank ↗

A new publication or filing at PHARMAVRAI? We notify you, reason included.

Follow PHARMAVRAI

Databakkes Pro

Know what changes at your customers, suppliers and competitors. Without reading an annual account.

Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.

Yes, I want that

See what a followed company gets: the De Lijn dossier

Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.

My folder 3 companies

De Lijn 8 June 2026 New annual account 2025

filed on 8 June 2026

What was left

€ 20 k ▼ 91%
Money in the bank

€ 178 k ▼ 98%

Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit

Real filings at the National Bank

Management

MARIE VANVOLSEM ANNABELLE MARIE VANVOLSEM CLARISSE

PHARMAVRAI

Behind PHARMAVRAI are MARIE VANVOLSEM ANNABELLE and MARIE VANVOLSEM CLARISSE.

See the full network in the app

Directors

According to the 2025 annual accounts

MARIE VANVOLSEM ANNABELLE

Director

MARIE VANVOLSEM CLARISSE

Director

Establishments

Establishment units

Physical locations of this company

Registered office

Rue Delloye-Matthieu 11

4500 Huy

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Website

HTTPS pharmavrai.com

Canonical: https://www.pharmavrai.com/

Technologies

Font AwesomeGoogle FontsNginx

Hosting & Email

Hosting

CLOUDFLARENET - Cloudflare, Inc., US

DNS

Cloudflare DNS

Domain

pharmavrai.com

Registered

2021-03-30

Registrar

HOSTINGER operations, UAB

Expires

2027-03-30

Website info

HTTPS Ja

Languages FR

Features

Webshop Contact page

Security

✓ HTTPS

✗ SPF

✗ DMARC

Network

✓ IPv6

✓ Load balancing

Details

Company number: 0552.535.853
VAT number: BE 0552.535.853
Registered office: Rue Delloye-Matthieu 11, 4500 Huy
Names & denominations: PHARMAVRAI
Enterprise type: Rechtspersoon
Legal form: Private limited company
Legal situation: Normale toestand
Start date: 8 May 2014
Peppol: Active · Active since 5 Dec 2025
Contact: pharmavrai.com
Activities · NACE: Detailhandel in farmaceutische producten

View on CBE Public ↗ Annual accounts (NBB) ↗